PRNewsWire - Health

Huntsville Memorial Hospital Reduces Patient Transfers and Enhances Local Care with Onsite EEG Program Powered by Zeto
Truemed and Navia Benefits Solutions Partner to Expand Access to Root-Cause Healthcare with HSA/FSA Dollars
New data show TREMFYA® (guselkumab) is the only IL-23 inhibitor proven to significantly inhibit progression of joint structural damage in active psoriatic arthritis
Statement from the American Nurses Association on the Department of Health and Human Services' Restructuring of the Advisory Committee for Immunization Practices